title: Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase.
authors.affiliation: Service d'Hématologie Clinique, Hôpital Archet 1, Nice, France.
authors.forename: Clémence
authors.initials: C
authors.lastname: Roux
authors.forename: Franck-Emmanuel
authors.initials: FE
authors.lastname: Nicolini
authors.forename: Delphine
authors.initials: D
authors.lastname: Rea
authors.forename: Mathilde
authors.initials: M
authors.lastname: Niault
authors.forename: Luigina
authors.initials: L
authors.lastname: Mollica
authors.forename: Françoise
authors.initials: F
authors.lastname: Berger
authors.forename: Catherine
authors.initials: C
authors.lastname: Chassagne-Clément
authors.forename: Isabelle
authors.initials: I
authors.lastname: Tigaud
authors.forename: Michel
authors.initials: M
authors.lastname: Tulliez
authors.forename: Stéphane
authors.initials: S
authors.lastname: Giraudier
authors.forename: Ali
authors.initials: A
authors.lastname: Turhan
authors.forename: Philippe
authors.initials: P
authors.lastname: Rousselot
authors.forename: Laurence
authors.initials: L
authors.lastname: Legros
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002908:Chronic Disease; D000069439:Dasatinib; D004334:Drug Administration Schedule; D057915:Drug Substitution; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced* / Q000473:pathology; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000473:pathology; D008198:Lymph Nodes / Q000187:drug effects / Q000473:pathology*; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib